Aleksandar Tepavac
Aleksandar Tepavac publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.
- World rank
- #5,884,671 of 7,710,434 ranked researchers
- Rank in Serbia
- #10,172 of 18,168
- Works
- 21
- Citations
- 68
- Citations per work
- 3.2
What does Aleksandar Tepavac research?
Aleksandar Tepavac's work is mostly in Medicine (72%), Agricultural and Biological Sciences (5%), Environmental Science (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1571.7%
- Medicine1571.7%
- Everything else418.3%
- Life Sciences16.7%
- Physical Sciences13.3%
- 1Pulmonary and Respiratory Medicine45% of their works
- 2Oncology20% of their works
- 3Cardiology and Cardiovascular Medicine7% of their works
- 4Plant Science5% of their works
- 5Nature and Landscape Conservation3% of their works
- 6Molecular Biology2% of their works
Research topics
Which keywords describe Aleksandar Tepavac's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer and Metastasis.
- Vascular Plants
- Conservation
- Biomass Estimation
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Small-Cell Lung Cancer
- Metastasis
- CT Screening
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Lung Cancer
- Genomic Profiles
- Anthracyclines
- Doxorubicin
- Allometric Models
- Cancer
- Inflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Clinical Trials182 topics
- Targeted Therapy182 topics
- Chemotherapy153 topics
- ALK Inhibitors131 topic
- EGFR Mutations131 topic
- CT Screening71 topic
- Lung Cancer71 topic
- Metastasis72 topics
- Genomic Profiles51 topic
- Small-Cell Lung Cancer51 topic
- Anthracyclines31 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Doxorubicin31 topic
- Taxanes31 topic
- Allometric Models21 topic
- Biomass Estimation21 topic
- Cancer21 topic
- Conservation21 topic
- Inflammation21 topic
- Vascular Plants21 topic
Where does Aleksandar Tepavac work?
Aleksandar Tepavac's main affiliation in the publication record is Institute for Pulmonary Diseases of Vojvodina, Serbia.
How many publications and citations does Aleksandar Tepavac have?
OpenAlex counts 21 works and 68 citations for Aleksandar Tepavac, an h-index of 3, ranking #5,884,671 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Aleksandar Tepavac. Posts are plain text and can be reported.